Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts

Hikaru Kato, Aika Kai, Tetsuro Kawabata, James D. Sunderhaus, Timothy J. McAfoos, Jennifer M. Finefield, Yukihiko Sugimoto, Robert M. Williams, Sachiko Tsukamoto

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The marine-derived Aspergillus protuberus MF297-2 and the terrestrial A. amoenus NRRL 35600 produce enantiomeric prenylated indole alkaloids. Investigation of biological activities of the natural and synthetic derivatives revealed that (−)-enantiomers of notoamides A and B, 6-epi-notoamide T, and stephacidin A inhibited receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL)–induced osteoclastogenic differentiation of murine RAW264 cells more strongly than their respective (+)-enantiomers. Among them, (−)-6-epi-notoamide T was the most potent inhibitor with an IC50 value of 1.7 μM.

Original languageEnglish (US)
Pages (from-to)4975-4978
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume27
Issue number22
DOIs
StatePublished - Nov 15 2017
Externally publishedYes

Keywords

  • Aspergillus
  • Enantiomer
  • Fungus
  • Notoamide
  • Osteoclastogenesis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Enantioselective inhibitory abilities of enantiomers of notoamides against RANKL-induced formation of multinuclear osteoclasts'. Together they form a unique fingerprint.

Cite this